ESC 365 - Doctor Iulia Rodionova

Speaker illustration

Doctor Iulia Rodionova

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)

Myeloperoxidase as a prognostic marker for adverse events in patients with chronic heart failure in 12 month follow-up

Event: Heart Failure 2023

Topic: Biomarkers

Session: ePosters in chronic heart failure 1

sST2 association with atrial fibrillation development in patients with acute myocardial infarction with ST elevation

Event: EHRA 2023

Topic: Cardiac Diseases

Session: ePoster session 51

The optimization of dual antiplatelet therapy in patients with ST-segment elevation myocardial infarction in dependence on the vasculoendothelial growth factor-A gene polymorphism G634C (rs2010963)

Event: Heart Failure 2021

Topic: Revascularisation

Session: ePoster session

Comparison of eplerenone and spyronolacton effects in prevention of left ventricular remodeling and development of heart failure in patients after STEMI

Event: Heart Failure 2019

Topic: Revascularisation

Session: Coronary Artery Disease

VEGF-A gene polymorphism and VEGF-A level association with the development of heart failure in patients with ST-elevation myocardial infarction

Event: Heart Failure 2019

Topic: Revascularisation

Session: Coronary Artery Disease

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources